Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) stock fell -8.46% on Thursday to $1.19 against a previous-day closing price of $1.30. With 1.4 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.29 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $1.4000 whereas the lowest price it dropped to was $1.1600. The 52-week range on SHPH shows that it touched its highest point at $126.26 and its lowest point at $1.02 during that stretch.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SHPH was up-trending over the past week, with a rise of 15.22%, but this was down by -23.23% over a month. Three-month performance dropped to -30.00% while six-month performance fell -30.81%.
Float and Shares Shorts:
At present, 13.65 million SHPH shares are outstanding with a float of 5.29 million shares on hand for trading. On Apr 27, 2023, short shares totaled 87480.0, which was 0.64% higher than short shares on Mar 30, 2023. In addition to Dr. Anatoly Dritschilo M.D. as the firm’s Co-Founder, MD, CEO & Chairman, Mr. Peter Dale Dritschilo M.B.A., M.D. serves as its Pres & COO.
Through their ownership of 1.01% of SHPH’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 48.80% of SHPH, in contrast to 0.22% held by mutual funds. Shares owned by individuals account for 0.04%. As the largest shareholder in SHPH with 0.18% of the stake, Qube Research & Technologies Ltd. holds 24,600 shares worth 24,600. A second-largest stockholder of SHPH, Millennium Management LLC, holds 10,824 shares, controlling over 0.08% of the firm’s shares. UBS Securities LLC is the third largest shareholder in SHPH, holding 0 shares or 0.00% stake. With a 0.04% stake in SHPH, the Fidelity Nasdaq Composite Index F is the largest stakeholder. A total of 4,926 shares are owned by the mutual fund manager. The BlackRock, which owns about 0.01% of SHPH stock, is the second-largest Mutual Fund holder. It holds 1,072 shares valued at 1769.0. Victory Extended Market Index Fun holds 0.00% of the stake in SHPH, owning 0 shares worth 0.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Dec 30, 2022, SHPH reported revenue of $0.00 and operating income of -$353.63k. The EBITDA in the recently reported quarter was -$337.18k and diluted EPS was -$0.05.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SHPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded SHPH stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has risen to 9 over the past year. The total number of shares bought during that period was 0 while 23,528 shares were sold.